Navigation Links
Genta Incorporated to Present Multiple Abstracts at the Annual,Meeting of the American Society of Clinical Oncology

BERKELEY HEIGHTS, N.J., May 25, 2007 /PRNewswire-FirstCall/ -- Genta Incorporated announced that several abstracts featuring its oncology products, Genasense(R) (oblimersen sodium) Injection, and Ganite(R) (gallium nitrate injection), will be presented at the 43rd annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, June 1-5, 2007. The abstracts include the following:

    -- LDH is a Prognostic Factor in Stage IV Melanoma Patients but is a

       Predictive Factor only for Bcl-2 Antisense Treatment Efficacy: Re-

       analysis of GM301 and EORTC18951 Randomized Trials.  Abstract #8552;

       Sunday, June 3, 2007.

    -- A Phase III Randomized Trial of Intensive Induction and Consolidation

       Chemotherapy +/- Oblimersen (Genasense; G3139), a Pro-Apoptotic Bcl-2

       Antisense Oligonucleotide, in Untreated Acute Myeloid Leukemia Patients

       greater than or equal to 60 Years Old: Cancer and Leukemia Group B

       (CALGB) Study 10201. Abstract #7012; Saturday, June 2, 2007.

    -- GaRD Study: Gallium, Rituximab, and Dexamethasone for Relapsed NHL.

       Poster #Y1, Abstract #8079; Saturday, June 2, 2007.

    -- Oblimersen (Genasense(R)) Can Be Administered by Subcutaneous and Brief

       Intravenous Infusion: Clinical Pharmacokinetics and Pharmacodynamics in

       Patients with Advanced Cancer. (Publication)

    -- Long-term Administration of Oblimersen plus Chemotherapy: An Analysis

       of Safety in Patients with Solid Tumors and Hematologic Cancers.

       (Publication)

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblim
'"/>




Page: 1 2 3

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference

Post Your Comments:
(Date:11/25/2009)...nd, Nov. 25 From November 16-18, ...ring solutions, presented the second edition of th...the special needs of the older population. The con...and audiology from around the world and more than ... with hearing loss for an opportunity to share exp...
(Date:11/25/2009)...RNewswire/ -- The FDA granted traditional approval...ucleoside reverse transcriptase inhibitor (NNRTI)....d for use in treatment-experienced adults who are ...resistant to an NNRTI and other antiretroviral (AR...8-week data from two Phase 3 studies known as DUET...
(Date:11/25/2009)... Remedium Technologies ...am that stops severe bleeding, won first prize and...ory of the Global Security Challenge 2009, company...e than 100 entries from around the world, Remedium...y Summit conference held at the London School of B...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 1The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 2The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection 13836 3Census Bureau News Media Advisory 3A Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56157 1Census Bureau News Media Advisory 3A Census Bureau to Announce Findings for Income Earnings Poverty and Health Insurance Coverage 56157 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 1Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 2Virginia Techs proposed next generation nano CT system will enhance nano scale research 56152 3
(Date:11/26/2009)...Kim of the Live Life Again Center, a practice offe...growing number of physicians who are taking advan... with individuals who are interested in surgical w...Kim is utilizing Facebook to share before-and-afte...he community. , Dallas, T...
(Date:11/26/2009)...munications announces a highly effective and uncon...uggling to make an economic recovery. , ...ars is the type of challenge that could send ailin...o Dr. David Benton, business growth expert and aut...ndash; The Rfactor Intensive . “Fear is o...
(Date:11/25/2009)...RNewswire-USNewswire/ -- When most people hear the...chiropractor can also give patients the help they ..., which is where your jaw (mandible) contacts/conn...ost common symptoms associated with TMJ dysfunctio...e jaw. But many other symptoms can be caused from...
(Date:11/25/2009)...v. 25 Onyx Pharmaceuti...he company will host two investor events in Decemb...09 - 9:00 a.m. CT/10:00 a.m. ET ,, Principal ...ounding carfilzomib in relapsed and/or refractory ... Society of Hematology (ASH) Annual Meeting and Ex...
(Date:11/25/2009)...wire/ - Sentinelle Medical Inc., a leading manufac...on software launches a suite of new leading edge c...ing software platform at this year,s Radiological ...Chicago, Nov. 30 - Dec. 5, 2009 (Booth 5800, Hall ...ity images generated by Sentinelle,s specialized M...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 4
...t blocks the effects of a newly developed anticanc...reat individuals with cancer that is resistant to ...erapies. Although promising clinical results have ...eam of researchers, led by Nick Lemoine and Yahoe ...
...nse to a press conference and statement issu... Hydroxycut weight loss products, the Council for ...ociation representing the dietary supplement indus... as well as the manufacturer of the Hydroxycut pro...
... is a statement of Matthew L. Myers, President Cam...dy presented Thursday at a scientific conference i...that U.S. smokers, risk of developing lung cancer ...f lung cancer compared to cigarettes smoked 40 yea...
...9, 2009, human cases of Swine Flu have been confir...ries worldwide and have been suspected in many oth...d Mexico. , , The World Health Organization warne...it is for a full-scale pandemic). , , Just how sa...
...ditionally, cancer biologists have embraced a simp...mor -- the "seed" -- was seen as bearing total res...ssues -- the "soil" in which the seed embedded its...eed but neglecting the role of the soil. , Recent...
...ho are blind or visually impaired are women , , ...s held a briefing, " Seeing Women: Taking on Gend...t the National Press Club in Washington, DC explor...effective strategies that work in improving access...
Other Medicine News:Health News:JCI online early table of contents: May 1, 2009 2Health News:JCI online early table of contents: May 1, 2009 3Health News:JCI online early table of contents: May 1, 2009 4Health News:JCI online early table of contents: May 1, 2009 5Health News:CRN Supports Recall of Hydroxycut Products 2Health News:New Study Indicates Changes in Cigarette Design Have Increased Lung Cancer Risk and Tobacco Regulation Can Greatly Reduce Lung Cancer 2Health News:New Study Indicates Changes in Cigarette Design Have Increased Lung Cancer Risk and Tobacco Regulation Can Greatly Reduce Lung Cancer 3Health News:New Study Indicates Changes in Cigarette Design Have Increased Lung Cancer Risk and Tobacco Regulation Can Greatly Reduce Lung Cancer 4Health News:From SARS to Swine Flu: Protecting Your Dental / Medical Practice 2Health News:Where tumor cells boldly go: Weill Cornell cancer biologists shed light on the metastatic niche 2Health News:NGOs Unite to Bring Awareness to Inequities in Eye Care for Women 2
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: